The Prognostic and Clinical Value of CD44 in Colorectal Cancer: A Meta-Analysis

Background: CD44 is widely used as a putative cancer stem cells (CSCs) marker for colorectal cancer (CRC). However, the prognostic role of CD44 in CRC remains controversial. Methods: We performed a systematic review and meta-analysis to evaluate the association of various CD44 isoforms and overall s...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhenpeng, Tang, Yufei, Xie, Lei, Huang, Aiping, Xue, Chunchun, Gu, Zhen, Wang, Kaiqiang, Zong, Shaoqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503057/
https://www.ncbi.nlm.nih.gov/pubmed/31114754
http://dx.doi.org/10.3389/fonc.2019.00309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503057/
https://www.ncbi.nlm.nih.gov/pubmed/31114754
http://dx.doi.org/10.3389/fonc.2019.00309

Ejemplares similares